The Benchmark Company Expands Its Biotechnology Focus With The Addition Of Dr. Aydin Huseynov And Dr. Okechukwu Linton NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, an institutionally focused research, sales & trading, and investment banking firm covering multiple sectors, including...

The Benchmark Company Announces Closing of Public Offering of $5m for Seelos Therapeutics, Inc. NEW YORK, Feb. 13, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company today announced the closing of an Underwritten Public Offering for Seelos Therapeutics, Inc. of 6,666,667 shares of common stock at...